Northwestern Mutual Wealth Management’s Avidity Biosciences RNAM Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15	Closed	-$1.08K	–	4418
2025 Q4	$1.08K	Buy	+15	New	+$969	﹤0.01%	3616
2025 Q2	–	Sell	-115	Closed	-$3.4K	–	3947
2025 Q1	$3.4K	Buy	115 +101	+721%	+$3.15K	﹤0.01%	3034
2024 Q4	$407	Sell	14 -26	-65%	-$1.09K	﹤0.01%	3404
2024 Q3	$1.84K	Buy	+40	New	+$1.74K	﹤0.01%	3130
2023 Q1	–	Sell	-3	Closed	-$67	–	3555
2022 Q4	$67	Buy	+3	New	+$45	﹤0.01%	3239
2022 Q3	–	Sell	-14	Closed	–	–	3349
2022 Q2	$0	Buy	+14	New	+$208	﹤0.01%	3429
2022 Q1	–	Sell	-5	Closed	–	–	3353
2021 Q4	$0	Buy	+5	New	+$119	﹤0.01%	3299

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Northwestern Mutual Wealth Management's RNAM Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 15 shares — an estimated $1.08K sold.

Northwestern Mutual Wealth Management first reported a position in RNAM in Q4 2021 and held it in 7 quarters. The position peaked at $3.4K in Q1 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Northwestern Mutual Wealth Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 15 Avidity Biosciences shares in Q1 2026, an estimated $1.08K.
Northwestern Mutual Wealth Management first reported a position in Avidity Biosciences in Q4 2021 and held it in 7 quarters.
Northwestern Mutual Wealth Management's Avidity Biosciences position peaked at $3.4K in Q1 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.